Systemic delivery of liposome-anchored anti-CD137 and IL2-Fc prevents lethal toxicity and elicits potent antitumor immunity

Benzer Materyaller

• Localized immunotherapy via liposome-anchored anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic anti-tumor immunity
  Yazar:: Kwong, Brandon, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
  Yazar:: Kwong, Brandon, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8(+) T cells
  Yazar:: Jung, Keunok, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity
  Yazar:: Yin, Pan, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
  Yazar:: Kowalsky, Stacy J., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)